ENDOGEN ApS: Financial statements 2013
CVR: 29813337
Source: annual report 2013, Danish Business Authority
27/10/2012 – 26/10/2013
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -13,995 and a net result of DKK -14,190 compared with DKK -1,156 the year before. Equity in the 2013 report amounted to DKK 106,914. The solvency ratio was 99.7%.
- Revenue
- DKK 0
- Gross Profit
- DKK -13,995
- Profit/Loss
- DKK -14,190
- Equity
- DKK 106,914
- Total Assets
- DKK 107,247
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 0 | -14 t. | -14 t. | 107 t. | - |
| 2012 | 0 | -990 | -1 t. | 121 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ENDOGEN ApS has published its annual report for 2012. Revenue came to DKK 0, and the net result was DKK -1,156.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.